Last reviewed · How we verify
rAAV-Olig001-ASPA — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
rAAV-Olig001-ASPA (rAAV-Olig001-ASPA) — Myrtelle Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| rAAV-Olig001-ASPA TARGET | rAAV-Olig001-ASPA | Myrtelle Inc. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- rAAV-Olig001-ASPA CI watch — RSS
- rAAV-Olig001-ASPA CI watch — Atom
- rAAV-Olig001-ASPA CI watch — JSON
- rAAV-Olig001-ASPA alone — RSS
Cite this brief
Drug Landscape (2026). rAAV-Olig001-ASPA — Competitive Intelligence Brief. https://druglandscape.com/ci/raav-olig001-aspa. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab